(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading to date, and reiterates its full-year revenue expectations. Read More
(Alliance News) - Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form business. Denmark-based Xellia Pharmaceuticals ApS. Read More
(Alliance News) - Stocks in London were seen higher early on Tuesday, as investors prepare for manufacturing purchasing managers' index data from both the US and Canada following Labor Day. Read More
Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Reports that Bassam Kanaan, executive vice president of corporate development and M&A, sold 35,000 shares at 1,960 pence each for GBP686,000 on Thursday. He subsequently sold 10,000 shares at 2,025p each for GBP202,500. Proceeds for the disposals total GBP888,500. Both transactions took place on the London Stock Exchange. Read More
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday increased its interim dividend following double-digit growth across the business in the first half. Read More
(Alliance News) - Hikma PLC's acquisition of assets from Denmark's Xellia Pharmaceuticals ApS is a sensible financial and strategic move, analysts on Monday said. Read More
(Alliance News) - Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmark's Xellia Pharmaceuticals ApS. Read More
(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England. Read More
